Zaheer-Ud-Din Babar
Impact in
- Health top 10%
- Vaccine Coverage and Hesitancy
-
- COVID-19 epidemiological studies
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 5
-
- Pharmacovigilance and Adverse Drug Reactions 3
- Co-authors
- Moyad Shahwan (1 shared paper)Faris El‐Dahiyat (2 shared papers)Ammar Abdulrahman Jairoun (1 shared paper)Rabia Hussain (7 shared papers)Sabaa Saleh Al‐Hemyari (1 shared paper)Inayat Ali (1 shared paper)Yuan Yang (1 shared paper)Siew Chin Ong (4 shared papers)
- Journals
- PLoS ONE (3 papers)Journal of Pharmaceutical Policy and Practice (2 papers)Frontiers in Pharmacology (2 papers)Global Health Research and Policy (1 paper)Research in Social and Administrative Pharmacy (1 paper)
- Partner nations
- United KingdomPakistanMalaysia
In The Last Decade
Zaheer-Ud-Din Babar
18 papers receiving 116 citations
Peers
Comparison fields: 5 of 39
- Health 45
- Modeling and Simulation 14
- Toxicology 9
- Geriatrics and Gerontology 6
- Family Practice 3
Countries citing papers authored by Zaheer-Ud-Din Babar
This map shows the geographic impact of Zaheer-Ud-Din Babar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaheer-Ud-Din Babar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaheer-Ud-Din Babar more than expected).
Fields of papers citing papers by Zaheer-Ud-Din Babar
This network shows the impact of papers produced by Zaheer-Ud-Din Babar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaheer-Ud-Din Babar. The network helps show where Zaheer-Ud-Din Babar may publish in the future.
Co-authors
The 25 scholars most cited alongside Zaheer-Ud-Din Babar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 37 | |
| 2 | 2022 | 12 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 9 | |
| 6 | 2020 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2024 | 4 | |
| 9 | 2022 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2021 | 0 |
About Zaheer-Ud-Din Babar
Zaheer-Ud-Din Babar is a scholar working on Geriatrics and Gerontology, Toxicology, Economics and Econometrics, Health and Finance, having authored 22 papers that have together received 117 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical Economics and Policy (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Antibiotic Use and Resistance (2 papers), Vaccine Coverage and Hesitancy (2 papers), Asthma and respiratory diseases (2 papers), Healthcare Systems and Reforms (2 papers) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Health (45 citations), Modeling and Simulation (14 citations), Toxicology (9 citations), Geriatrics and Gerontology (6 citations) and Family Practice (3 citations). Zaheer-Ud-Din Babar has collaborated with scholars based in United Kingdom, Pakistan and Malaysia. Frequent co-authors include Moyad Shahwan, Faris El‐Dahiyat, Ammar Abdulrahman Jairoun, Rabia Hussain, Sabaa Saleh Al‐Hemyari, Inayat Ali, Yuan Yang, Siew Chin Ong, Caijun Yang and Bandana Saini. Their work appears in journals such as PLoS ONE, Journal of Pharmaceutical Policy and Practice, Frontiers in Pharmacology, Global Health Research and Policy and Research in Social and Administrative Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.